Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online November 1, 2015.
Article Versions
- Latest version (May 1, 2015 - 04:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2015
Author Information
- William Tillett,
- Lihi Eder,
- Niti Goel,
- Maarten De Wit,
- Dafna D. Gladman,
- Oliver FitzGerald,
- Willemina Campbell,
- Philip S. Helliwell,
- Laure Gossec,
- Ana-Maria Orbai,
- Alexis Ogdie,
- Vibeke Strand,
- Neil J. McHugh and
- Philip J. Mease⇑
- From the Royal National Hospital for Rheumatic Diseases, Bath, UK; Toronto Western Hospital; Psoriatic Arthritis Program, University Health Network, Toronto Western Research Institute, Toronto, Ontario, Canada; St. Vincent’s University Hospital, Dublin, Ireland; Quintiles; Duke University School of Medicine; Durham, North Carolina, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; Chapel Allerton Hospital, Leeds, UK; Sorbonne Universités, Université Pierre et Marie Curie—Paris 6 (UPMC Univ Paris 6), Institut Pierre Louis d’Epidémiologie et de Santé Publique; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, Maryland; Division of Immunology/Rheumatology, Stanford University School of Medicine, Portola Valley, California, USA; University of Bath, Bath, UK; Swedish Medical Center, University of Washington, Seattle, Washington; Hospital of the University of Pennsylvania (HUP), Philadelphia, Pennsylvania, USA.
- W. Tillett*, MB, ChB, BSc, MRCP, PhD, Research Fellow, Royal National Hospital for Rheumatic Diseases; L. Eder*, MD, PhD, Postdoctoral Research Fellow, Toronto Western Hospital; M. de Wit, PhD, OMERACT Patient Research Partner, The Netherlands; D.D. Gladman, MD, FRCPC, Director, Psoriatic Arthritis Program, University Health Network, Senior Scientist, Toronto Western Research Institute; O. FitzGerald, MD, FRCPI, FRCP( UK), Consultant Rheumatologist and Newman Clinical Research Professor, St. Vincent’s University Hospital; N. Goel, MD, OMERACT Patient Research Partner, Quintiles, and Duke University School of Medicine; W. Campbell, BEd, LLB, OMERACT Patient Research Partner; P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital; L. Gossec, MD, PhD, Sorbonne Universités, UPMC Univ Paris 6, Institut Pierre Louis d’Epidémiologie et de Santé Publique, and AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; A.M. Orbai, MD, MHS, Johns Hopkins University School of Medicine, Division of Rheumatology; A. Ogdie, MD, MSCE, HUP; V. Strand, MD, Biopharmaceutical Consultant and Adjunct Clinical Professor, Division of Immunology/Rheumatology, Stanford University School of Medicine; N.J. McHugh, MBChB, MD, FRCP, FRCPath, Professor of Pharmacy and Pharmacology, University of Bath, and Consultant Rheumatologist, Royal National Hospital for Rheumatic Diseases; P.J. Mease, MD, Director, Rheumatology Research, Swedish Medical Center and Clinical Professor, University of Washington.
- Address correspondence to Prof. P.J. Mease, Rheumatology Research, Swedish Medical Center, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease{at}philipmease.com
↵* Drs. Tillett and Eder contributed equally to this work.
Article usage
Statistics from Altmetric.com
In this issue
Enhanced Patient Involvement and the Need to Revise the Core Set — Report from the Psoriatic Arthritis Working Group at OMERACT 2014
